+ Site Statistics
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Detection and estimation of human papillomavirus viral load in patients with cervical lesions

Detection and estimation of human papillomavirus viral load in patients with cervical lesions

Bangladesh Medical Research Council Bulletin 39(2): 86-90

Human papillomavirus (HPV) high risk genotype infection and HPV viral load influences the development of invasive cervical cancer and cervical intra-epithelial neoplasia (CIN). HPV DNA testing for screening of cervical cancers may play a potential role in its early detection and management. The present study detected HPV DNA and estimated HPV viral load in different types of cervical lesions among Bangladeshi women. Using the Hybrid Capture 2 (HC2) assay, HPV DNA was tested among 68 women between 25-70 years of age. A total of 13 (19.1%) cases were positive for HPV DNA. The highest viral load (501 x 10(3) copies/ml) was detected in a patient with invasive carcinoma, while the lowest viral load (105 x 10(3) copies/ml) was detected from a case of chronic cervicitis. The mean viral load in CIN I was 119.25 x 10(3) +/- 12.5 x 10(3) copies/ml (range: 110 x 10(3) - 137 x 10(3) ) and 208.50 x 10(3) +/- 0.59 x 10(3) copies/ml (range: 139 x 10(3) - 305 x 10(3)) in CIN II/III. Interestingly, HPV DNA was detected from a patient with normal cytological findings. Our study observed a moderate presence of high-risk HPV genotypes among women with cervical lesions. The HPV viral load varied with the age of the patients and stage of cervical lesions. The HC2 assay is a promising tool for diagnosing high-risk HPV infection especially before cytology tests show any abnormality.

(PDF emailed within 0-6 h: $19.90)

Accession: 052515178

Download citation: RISBibTeXText

PMID: 24930198

DOI: 10.3329/bmrcb.v39i2.19648

Related references

Viral load of high-risk human papillomavirus in cervical squamous intraepithelial lesions. International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics 76(1): 41-47, 2002

Viral load, genomic integration frequency of human papillomavirus 16 in cervical cancer and precancerous lesions. Zhonghua Yi Xue Za Zhi 91(13): 906-910, 2011

Molecular detection of human papillomavirus and viral DNA load after radiotherapy for cervical carcinomas. Tumori 102(5): 521-526, 2015

Analysis of the dose-response relationship between high-risk human papillomavirus viral load and cervical lesions. Transactions of the Royal Society of Tropical Medicine and Hygiene 103(8): 779-784, 2010

Association of human papillomavirus viral load and risk of cervical squamous intraepithelial lesions among multiethnic women in Hawaii. Proceedings of the American Association for Cancer Research Annual Meeting 40: 444, 1999

Local immunosuppression induced by high viral load of human papillomavirus: characterization of cellular phenotypes producing interleukin-10 in cervical neoplastic lesions. Immunology 146(1): 113-121, 2015

Association between human papillomavirus (HPV) 16, HPV18, and other HR-HPV viral load and the histological classification of cervical lesions: Results from a large-scale cross-sectional study. Journal of Medical Virology 89(3): 535-541, 2016

Prognostic significance of human papillomavirus viral load in correlation with different therapeutic modalities in cervical cancer patients. Pathology, Research and Practice 212(9): 804-810, 2017

Low initial human papillomavirus viral load may indicate worse prognosis in patients with cervical carcinoma treated with surgery. Journal of Gynecologic Oncology 26(2): 111-117, 2016

Detection of E2 gene polymorphism of human papillomavirus type 16 in patients with cervical lesions and cervical cancer. Nan Fang Yi Ke Da Xue Xue Bao 32(10): 1503-1506, 2013

High human papillomavirus oncogene mRNA expression and not viral DNA load is associated with poor prognosis in cervical cancer patients. Clinical Cancer Research 13(1): 132-138, 2007

Detection of autoantibodies to survivin in cervical mucus from patients with human papillomavirus-associated cervical cancer and precursor lesions. Autoimmunity 40(1): 66-72, 2007

Serial measurement of type-specific human papillomavirus load enables classification of cervical intraepithelial neoplasia lesions according to occurring human papillomavirus-induced pathway. European Journal of Cancer Prevention 26(2): 156-164, 2016

Quantitative real-time polymerase chain reaction analysis of the type distribution, viral load, and physical status of human papillomavirus in liquid-based cytology samples from cervical lesions. International Journal of Gynecological Cancer 18(1): 121-127, 2007

Partner Human Papillomavirus Viral Load and Incident Human Papillomavirus Detection in Heterosexual Couples. Journal of Infectious Diseases 213(6): 948-956, 2016